Select Page

Camber Pharmaceutical is launching lidocaine HCl injection in two concentrations, 1% and 2%, as well as in single-dose and multi-dose vials. The various vial and pack sizes are designed to cater to different healthcare needs. According to Camber, it is a significant milestone to introduce this product, noting that the company has acquired the approval for the second-highest number of FDA-approved generics in the generic pharmaceutical industry.